Maintenance sunitinib in patients with advanced bladder cancer who responded to initial chemotherapy

Trial Profile

Maintenance sunitinib in patients with advanced bladder cancer who responded to initial chemotherapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2012

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Feb 2012 New trial record
    • 04 Feb 2012 Results presented at the 2012 Genitourinary Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top